Q3 2013 Holdings
Filed 2013-11-14 | 26 holdings | $14.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec Inc(BIIB) | COM | 09062X103 | $14.4M | 60,000 | 97.4% |
| NPS Pharmaceuticals Inc | COM | 62936P103 | $43.1K | 1,355,152 | 0.3% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $36.9K | 468,190 | 0.2% |
| Furiex Pharmaceuticals Inc | COM | 36106P101 | $33.5K | 761,764 | 0.2% |
| Wuxi Pharmatech Cayman Inc | SPONS ADR SHS | 929352102 | $27.4K | 1,001,514 | 0.2% |
| Medicines Co | COM | 584688105 | $24.9K | 741,355 | 0.2% |
| Affymetrix Inc | COM | 00826T108 | $21.3K | 3,442,140 | 0.1% |
| Amag Pharmaceuticals Inc(AMAG) | COM | 00163U106 | $20.3K | 943,037 | 0.1% |
| Taro Pharmaceutical Inds LTD | SHS | M8737E108 | $19.8K | 260,083 | 0.1% |
| Emergent Biosolutions Inc(EBS) | COM | 29089Q105 | $19.7K | 1,033,869 | 0.1% |
| Salix Pharmaceuticals Inc | COM | 795435106 | $19.2K | 287,779 | 0.1% |
| Cardiovascular SYS Inc del(CSIIEUR) | COM | 141619106 | $17.6K | 878,254 | 0.1% |
| Endo Health Solutions Inc | COM | 29264F205 | $17.3K | 380,300 | 0.1% |
| Insys Therapeutics Inc New | COM NEW | 45824V209 | $14.3K | 407,865 | 0.1% |
| Orthofix Intl N V | COM | N6748L102 | $13.3K | 642,726 | 0.1% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $13.1K | 569,493 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $8.6K | 141,500 | 0.1% |
| Anacor Pharmaceuticals Inc | COM | 032420101 | $7.8K | 737,685 | 0.1% |
| Chindex International Inc | COM | 169467107 | $6.0K | 353,429 | 0.0% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $5.6K | 304,460 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $5.6K | 507,469 | 0.0% |
| Sucampo Pharmaceuticals Inc | CL A | 864909106 | $5.3K | 855,214 | 0.0% |
| Liposcience Inc | COM | 53630M108 | $2.2K | 445,052 | 0.0% |
| Hyperion Therapeutics Inc | COM | 44915N101 | $2.2K | 83,142 | 0.0% |
| Horizon Pharma Inc | COM | 44047T109 | $352 | 105,000 | 0.0% |
| Celgene Corp | RIGHT 12/31/2030 | 151020112 | $111 | 13,770 | 0.0% |